Dexcom’s Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor (CGM), is now available for purchase without a prescription. The device is designed for people 18 and older with Type 2 diabetes who do not use insulin and those with prediabetes, offering personalized insights into glucose levels without painful finger pricks.
Tonix Pharmaceuticals has partnered with Bilthoven Biologicals to advance its mpox vaccine candidate, TNX-801. This collaboration aims to develop a safe and effective vaccine to combat the growing threat of mpox, especially in light of the recent WHO public health emergency declaration.
The DRIPBaR, a leading IV therapy franchise, is expanding into Canada with Dr. Steve Rallis appointed as Chief Medical Officer. Dr. Rallis, a renowned naturopathic physician, will oversee all medical aspects of The DRIPBaR’s operations in Canada, ensuring the highest standards of quality and safety for its innovative IV vitamin therapies.
MIRA Pharmaceuticals’ oral ketamine analog, Ketamir-2, has demonstrated significant potential in reversing neuropathic pain in a recent preclinical study. The drug showed superior efficacy compared to traditional oral ketamine, achieving complete normalization of pain thresholds in rats. MIRA is optimistic about the potential of Ketamir-2 for treating neuropathic pain and cancer-induced depression, with human trials potentially starting as early as 2025.
The UK’s National Health Service (NHS) is expected to follow the National Institute for Health and Care Excellence (NICE) in rejecting Eli Lilly’s donanemab, a potential Alzheimer’s treatment, due to safety concerns, high costs, and a precedent set by the rejection of Biogen’s Leqembi. While donanemab showed promising results in slowing cognitive decline, the risks of brain bleeds and swelling, occurring at a higher rate than with Leqembi, are major concerns. The projected cost of donanemab, estimated to be 25% higher than Leqembi, adds to the concerns, with NICE already citing cost as a primary factor in its rejection of Leqembi.
Summer’s sun can be beautiful, but it also takes a toll on our skin and hair. Nutritionist Luis Alberto Zamora explains how a summer diet rich in hydration, antioxidants, and vitamins can help protect and nourish our skin from the inside out.
The global parenteral drug market is poised for significant growth, driven by increasing demand for effective and quick-acting treatments. This market is expected to reach a value of US$ 595.63 billion in 2024, expanding at a CAGR of 5.5% over the forecast period from 2024 to 2034.
Malawi has introduced mandatory Mpox screening at all entry ports following the identification of two suspected cases. The country is taking precautionary measures to prevent a potential outbreak, despite having avoided a significant Mpox spread previously. The Health Ministry is preparing for a worst-case scenario and has established a mobile diagnostic unit and launched awareness campaigns.
The global aplastic anemia market is expected to experience significant growth over the next decade, driven by a surge in research activities, the introduction of novel treatment options, and an increasing focus on improving patient outcomes. This market is projected to reach US$ 10.8 billion by 2034, with a CAGR of 4.3% from 2024 to 2034.
TikTok Shop is selling Lily of the Valley tea, which is highly poisonous and can be fatal. Medical experts are urging users to avoid this dangerous trend and highlighting the potential risks of purchasing untested products online.
